Replacing a laptop or phone right away is not always possible. When something breaks without warning, a used device can feel like the only practical option.

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Packing for international travel sits somewhere between art and an anxiety-inducing puzzle. Pack too much and you’re lugging unnecessary weight through airports, trains, and cobblestone streets. Pack ...

Want music on your outdoor runs without losing street awareness? See how open‑ear and bone‑conduction headphones stack up.

Yep, the most slept-on feature in streaming is the Fire TV's unrivaled cloud gaming support. Here's everything we know about the allegations against the Orlando woman arrested in connection with the ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Palo Alto Networks (NasdaqGS ...

Source 1 Solutions, an enterprise technology infrastructure company headquartered in Clearwater, Florida, today announced a significant expansion of its digital presence across the state through a new ...

As the snow begins to melt and the temperatures rise, black bears in Connecticut are set to re-emerge and become active, just as state officials are urging people to take precautions and know how to ...

The launch of Sri Lanka’s first locally manufactured self-dialysis solution bags by Kelun Lifesciences has coincided with the World Kidney Day. The company said the new supply bags, designed for ...

F10 Antiseptic Wound Spray with Insecticide received the EUA based on scientific evidence available. The FDA announced earlier this week it issued an Emergency Use Authorization (EUA) for benzalkonium ...

After more than 160 years, the AVMA welcomed its first Black president, marking a new chapter in the organization’s history. In 1863, 40 veterinary surgeons representing New York, Massachusetts, Maine ...

UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...